Pellagra

Pellagra is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under: Nutritional and Metabolic Diseases
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Niacin

Resolves to

Vocabularies

MeSHM0016099ICD-10E52SNOMED CT154725000MedDRA10029400UMLSC0030783

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Pellagra share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.